Drug Profile
Mivotilate
Alternative Names: YH-439Latest Information Update: 08 Nov 2010
Price :
$50
*
At a glance
- Originator Yuhan
- Class Hepatoprotectants; Small molecules; Thiazoles
- Mechanism of Action Lipid peroxidation inhibitors; Protein synthesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Hepatitis B
Most Recent Events
- 08 Nov 2010 Discontinued - Phase-II for Hepatitis B in Germany (PO)
- 08 Nov 2010 Discontinued - Phase-II for Hepatitis B in South Korea (PO)
- 08 Nov 2010 Discontinued - Preclinical for Cancer (Prevention)/Chemoprevention in USA (PO)